Concepedia

Nivalis Therapeutics (United States)

NT

Statistics

Publications

181

Citations

36.4K

Authors

84

Location

Boulder, United States

Also known as N30 Pharmaceuticals

Nivalis Therapeutics (United States) is a company institution in Boulder, United States known for medicine, molecular biology, and natural sciences.

HomepageROR

Top concepts

Publications

181

Oligonucleotide inhibitors of human thrombin that bind distinct epitopes

Diane M. Tasset, Mark F. Kubik, Walter W. Steiner · Journal of Molecular Biology · 1997 · 830 citations

, , +6

2′-Fluoropyrimidine RNA-based Aptamers to the 165-Amino Acid Form of Vascular Endothelial Growth Factor (VEGF165)

Judy Ruckman, Louis S. Green, Jim Beeson et al. · Journal of Biological Chemistry · 1998 · 731 citations · Full text

Optimized dynamical decoupling in a model quantum memory

Michael J. Biercuk, Hermann Uys, Aaron P. VanDevender et al. · Nature · 2009 · 626 citations · Full text

, , +7

Tumor targeting by an aptamer.

Brian J. Hicke, Andrew Stephens, Ty Gould et al. · PubMed · 2006 · 383 citations

RNA-catalysed carbon–carbon bond formation

Theodore M. Tarasow, Sandra L. Tarasow, Bruce E. Eaton · Nature · 1997 · 364 citations

, , +5

1–5 of 181

Authors

84

  1. DW
    Daniel W. Drolet

    Nivalis Therapeutics (United States), United States

    47 publications · 2.7K citations

    24

    h-index

  2. TM
    Theodore M. Tarasow

    Nivalis Therapeutics (United States), United States

    55 publications · 1.7K citations

    23

    h-index

  3. PA
    P A Pavco

    Nivalis Therapeutics (United States), United States

    39 publications · 1.6K citations

    20

    h-index

  4. JA
    James A. McSwiggen

    Nivalis Therapeutics (United States), United States

    31 publications · 2.4K citations

    18

    h-index

  5. LS
    Louis S. Green

    Nivalis Therapeutics (United States), United States

    21 publications · 2.3K citations

    17

    h-index

1–5 of 84